Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.640
0.00 (0.00%)
At close: Jun 18, 2026, 4:00 PM EDT
1.650
+0.010 (0.58%)
After-hours: Jun 18, 2026, 7:36 PM EDT
Caribou Biosciences Revenue
Caribou Biosciences had revenue of $2.40M in the quarter ending March 31, 2026, with 1.87% growth. This brings the company's revenue in the last twelve months to $11.20M, up 12.96% year-over-year. In the year 2025, Caribou Biosciences had annual revenue of $11.16M with 11.66% growth.
Revenue (ttm)
$11.20M
Revenue Growth
+12.96%
P/S Ratio
14.52
Revenue / Employee
$115,495
Employees
97
Market Cap
162.66M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.16M | 1.17M | 11.66% |
| Dec 31, 2024 | 9.99M | -24.48M | -71.01% |
| Dec 31, 2023 | 34.48M | 20.63M | 148.91% |
| Dec 31, 2022 | 13.85M | 4.25M | 44.31% |
| Dec 31, 2021 | 9.60M | -2.76M | -22.35% |
| Dec 31, 2020 | 12.36M | 6.57M | 113.56% |
| Dec 31, 2019 | 5.79M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Precision BioSciences | 45.07M |
| Innate Pharma | 10.57M |
| Oramed Pharmaceuticals | 2.00M |
| Kazia Therapeutics | 1.27M |
| YD Bio | 510.36K |
CRBU News
- 4 days ago - Caribou Biosciences Transcript: AGM 2026 - Transcripts
- 10 days ago - Caribou Biosciences presents ANTLER trial results at EHA - TheFly
- 10 days ago - Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026 - GlobeNewsWire
- 10 days ago - Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting - GlobeNewsWire
- 11 days ago - Caribou Biosciences Slides: Corporate presentation - Filings
- 16 days ago - Caribou Biosciences Proxy statement: Proxy filing - Filings
- 17 days ago - Caribou Biosciences Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 25 days ago - Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire